Literature DB >> 21718568

Chlamydia (uncomplicated, genital).

Paddy Horner1.   

Abstract

INTRODUCTION: Genital chlamydia is the most commonly reported bacterial sexually transmitted infection (STI) in developed countries. In women, infection occurs most commonly between the ages of 16 and 19 years. METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of antibiotic treatment for men and non-pregnant women with uncomplicated genital chlamydial infection?What are the effects of antibiotic treatment for pregnant women with uncomplicated genital chlamydial infection? We searched: Medline, Embase, The Cochrane Library, and other important databases up to September 2009 (Clinical Evidence reviews are updated periodically; please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
RESULTS: We found 24 systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.
CONCLUSIONS: In this systematic review we present information relating to the effectiveness and safety of the following interventions: amoxicillin, ampicillin, azithromycin, ciprofloxacin, clarithromycin, clindamycin, doxycycline, erythromycin, lymecycline, minocycline, ofloxacin, pivampicillin, rifampicin, roxithromycin, sparfloxacin, tetracycline, and trovafloxacin.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21718568      PMCID: PMC2907609     

Source DB:  PubMed          Journal:  BMJ Clin Evid        ISSN: 1462-3846


  36 in total

1.  The natural course of Chlamydia trachomatis infection in asymptomatic Colombian women: a 5-year follow-up study.

Authors:  Monica Molano; Chris J L M Meijer; Elisabete Weiderpass; Annie Arslan; Hector Posso; Silvia Franceschi; Margarita Ronderos; Nubia Muñoz; Adriaan J C van den Brule
Journal:  J Infect Dis       Date:  2005-02-09       Impact factor: 5.226

2.  Recurrent chlamydial infections increase the risks of hospitalization for ectopic pregnancy and pelvic inflammatory disease.

Authors:  S D Hillis; L M Owens; P A Marchbanks; L F Amsterdam; W R Mac Kenzie
Journal:  Am J Obstet Gynecol       Date:  1997-01       Impact factor: 8.661

3.  Ciprofloxacin compared with doxycycline for nongonococcal urethritis. Ineffectiveness against Chlamydia trachomatis due to relapsing infection.

Authors:  T M Hooton; M E Rogers; T G Medina; L E Kuwamura; C Ewers; P L Roberts; W E Stamm
Journal:  JAMA       Date:  1990-09-19       Impact factor: 56.272

4.  Efficacy and safety of azithromycin versus lymecyline in the treatment of genital chlamydial infections in women.

Authors:  C Brihmer; P A Mårdh; I Kallings; S Osser; M Röbech; B Sikström; L Wanger
Journal:  Scand J Infect Dis       Date:  1996

5.  The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after one-year follow-up.

Authors:  Servaas A Morré; Adriaan J C van den Brule; Lawrence Rozendaal; A Joan P Boeke; Feja J Voorhorst; Sjoerd de Blok; Chris J L M Meijer
Journal:  Int J STD AIDS       Date:  2002-12       Impact factor: 1.359

Review 6.  Repeat infection with Chlamydia and gonorrhea among females: a systematic review of the literature.

Authors:  Christina B Hosenfeld; Kimberly A Workowski; Stuart Berman; Akbar Zaidi; Jeri Dyson; Debra Mosure; Gail Bolan; Heidi M Bauer
Journal:  Sex Transm Dis       Date:  2009-08       Impact factor: 2.830

Review 7.  Sexually transmitted diseases and infertility.

Authors:  L V Weström
Journal:  Sex Transm Dis       Date:  1994 Mar-Apr       Impact factor: 2.830

8.  A preliminary study of clarithromycin versus doxycycline in the treatment of nongonococcal urethritis and mucopurulent cervicitis.

Authors:  G E Stein; N L Mummaw; D H Havlichek
Journal:  Pharmacotherapy       Date:  1995 Nov-Dec       Impact factor: 4.705

9.  Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials.

Authors:  Chuen-Yen Lau; Azhar K Qureshi
Journal:  Sex Transm Dis       Date:  2002-09       Impact factor: 2.830

10.  A comparative study of two different regimens of sparfloxacin versus doxycycline in the treatment of non-gonococcal urethritis in men.

Authors:  I Phillips; C Dimian; D Barlow; H Moi; E Stolz; W Weidner; E Perea
Journal:  J Antimicrob Chemother       Date:  1996-05       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.